代谢
二苯并[b,f]-1,4-[11(14)-C]恶嗪(CR)在大鼠、恒河猴和豚鼠以及离体灌注的大鼠肝脏中的命运已经得到了研究。以1.56至3470微摩尔/千克的剂量给大鼠注射14C-CR,无论剂量或给药途径如何,大部分(59-93%)以7-、4-和9-羟基化10,11-二氢二苯并[b,f]-1,4-恶嗪-11(10H)-酮的硫酸盐形式在尿液中排出。在血液中,无论是在体内还是在肝脏灌注液中,CR的浓度都呈双相下降,最初被CR-内酰胺(二氢二苯并[b,f]-1,4-恶嗪-11(10H)-酮)取代,随后是7-、4-和9-羟基内酰胺的硫酸盐。CR在肝脏灌注液中的消失速率比在体内慢。胆汁中只含有少量的硫酸盐共轭物和大量的共轭2-氨基-2'-羟甲基二苯基醚(氨基醇)。在鼠尿或血液中未发现此物质。对恒河猴和豚鼠的初步研究表明,它们的排泄模式和代谢物相似。然而,只有自由的羟基内酰胺从猴尿中分离出来,豚鼠尿液中检测到氨基醇的痕迹。小鼠的全身体部放射自显影证实了CR从血液迅速进入心脏、肝脏、肾脏和小肠,并有胆汁排出的证据。这与大鼠的研究一致,表明高度亲脂性化合物被迅速吸收,经过肝脏代谢、胆汁分泌、肠肝循环和肾脏排泄。
The fate of dibenz[b,f]-1,4-[11(14)-C]oxazepine (CR) in rats, rhesus monkey and guinea-pig and in isolated perfused rat livers has been examined. 14C-CR was administered to rats at doses from 1.56 to 3470 umol/kg and irrespective of dose or route of administration most (59-93%) was eliminated in the urine as primarily the sulfates of the 7-, 4- and 9-hydroxylated 10,11-dihydrodibenz[b,f]-1,4-oxazepine-11(10H)-one. In blood, both in vivo and in liver perfusates, CR concentrations decreased biphasically to be replaced initially with CR-lactam (dihydrodibenz[b,f]-1,4-oxazepine-11(10H)-one), followed by the sulfates of the 7-, 4- and 9-hydroxylactams. The rate of disappearance of CR in liver perfusates was slower than in vivo. Bile contained only small amounts of sulphate conjugates and significant amounts of conjugated 2-amino-2'-hydroxymethyldiphenyl ether (amino alcohol). This was not identified in the urine or blood of rats. Preliminary studies in rhesus monkey and the guinea-pig show similar excretory patterns and metabolites. However, only free hydroxylactams were isolated from monkey urine and traces of the amino alcohol were detected in guinea-pig urine. Whole-body autoradiography of mice confirm the rapid disappearance of CR from blood into heart, liver, kidneys and small intestine with evidence of biliary excretion. It is consistent with the rat studies showing the rapid absorption of a highly lipophilic compound undergoing hepatic metabolism, biliary secretion, enterohepatic recirculation and renal excretion. /Dibenz[b,f]-1,4-[11(14)-C]oxazepine (CR)/
来源:Hazardous Substances Data Bank (HSDB)